drugset / Trial / NCT02438852

Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer

NCT02438852

RandomizedParallel-groupDouble-blindSupportive care

Summary

This randomized phase IV trial studies how well the continuous infusion of ropivacaine hydrochloride works in reducing pain after surgery in patients with bladder cancer. Ropivacaine hydrochloride is an anesthetic drug used to decrease pain by numbing an area of the body without putting the patient to sleep. Continuous infusion of ropivacaine hydrochloride may reduce pain and improve the quality of life for patients after bladder surgery.

Timeline

Start
2019-02-25
Primary completion
2021-02-25
Completion
2022-02-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified Intravenous